Dissecting oncogenes and tyrosine kinases in AML cells
Bianchi, E.; Rogge, L.
Medgenmed Medscape General Medicine 5(3): 10
2003
ISSN/ISBN: 1531-0132 PMID: 14600647 Document Number: 562074
Document emailed within 1 workday
Related Documents
Kiselev, L.L. 1985: Oncoproteins--the products of oncogenes. Tyrosine protein kinases Molekuliarnaia Biologiia 19(2): 309-332Cheburkin, I.V.; Kniazeva, T.G.; Peter, S.; Kniazev, I.P.; Karelin, M.I.; Shkol'nik, M.I.; Evtushenko, V.I.; Hanson, K.P.; Ullrich, A.; Kniazev, P.G. 2002: Molecular portrait of human kidney carcinomas: the gene expression profiling of protein-tyrosine kinases and tyrosine phosphatases which controlled regulatory signals in the cells Molekuliarnaia Biologiia 36(3): 480-490
Suda, T.; Iwama, A.; Hashiyama, M.; Sakano, S.; Ohno, M. 1997: Receptor tyrosine kinases involved in hematopoietic progenitor cells Leukemia 11(Suppl 3): 451-453
Freedman, S.D.; Katz, M.H.; Parker, E.M.; Gelrud, A. 1999: Endocytosis at the apical plasma membrane of pancreatic acinar cells is regulated by tyrosine kinases American Journal of Physiology 276(2): C306-C311
Turkina, A.G.; Domracheva, E.V.; Vorontsova, A.V.; Aseeva, E.A.; Vinogradova, O.I.; Stakhina, O.V.; Gusarova, G.A.; Diagileva, O.A.; Semenova, E.A.; Vakhrusheva, M.V.; Kolosheĭnova, T.I.; Abakumov, E.M.; Chelysheva, E.I.; Goriacheva, S.R.; Ivanova, T.V.; Zakharova, E.S.; Kolosova, L.I.; Zakharova, A.V.; Naumova, I.N.; Diachenko, L.V.; Kulikov, S.M.; Kovaleva, L.G.; Khoroshko, N.D. 2009: Trisomy of chromosome 8 in Ph-negative cells of the bone marrow in patients with chronic myeloid leukemia treated with inhibitors of BCR-ABL tyrosine kinases Terapevticheskii Arkhiv 81(7): 29-36
Song, L.; Ding, S.; Ge, Z.; Zhu, X.; Qiu, C.; Wang, Y.; Lai, E.; Yang, W.; Sun, Y.; Chow, S.A.; Yu, L. 2018: Nucleoside/nucleotide reverse transcriptase inhibitors attenuate angiogenesis and lymphangiogenesis by impairing receptor tyrosine kinases signalling in endothelial cells British Journal of Pharmacology 175(8): 1241-1259
Junger, W.G.; Hoyt, D.B.; Hamreus, M.; Liu, F.C.; Herdon-Remelius, C.; Junger, W.; Altman, A. 1997: Hypertonic saline activates protein tyrosine kinases and mitogen-activated protein kinase p38 in T-cells Journal of Trauma 42(3): 437-43; Discussion 443-5
Blay, J.Y.; Puisieux, A. 2000: Cancer cells. Genetic anomalies (oncogenes and anti-oncogenes), growth factors, apoptosis and dissemination, prognostic impact La Revue du Praticien 50(10): 1135-1144
Zhou, Y.; Tanaka, T.; Sakurai, H. 2013: Regulation of receptor tyrosine kinases by Ser/Thr phosphorylation Seikagaku. Journal of Japanese Biochemical Society 85(6): 462-468
Courtneidge, S.A. 1994: Protein tyrosine kinases, with emphasis on the Src family Seminars in Cancer Biology 5(4): 239-246
Schneble, N.; Wetzker, R.; Wollina, U. 2016: Lipedema lack of evidence for the involvement of tyrosine kinases Journal of Biological Regulators and Homeostatic Agents 30(1): 161-163
Buzzetti, F.; Brasca, M.G.; Crugnola, A.; Fustinoni, S.; Longo, A.; Penco, S.; Dalla Zonca, P.; Comoglio, P.M. 1993: Cinnamamide analogs as inhibitors of protein tyrosine kinases Farmaco 48(5): 615-636
Chan, J.; Watt, V.M. 1991: Eek and erk, new members of the eph subclass of receptor protein-tyrosine kinases Oncogene 6(6): 1057-1061
Ohnishi, H. 2011: Regulation of the adult brain function by Src family tyrosine kinases Seikagaku. Journal of Japanese Biochemical Society 83(11): 1054-1059
Liu, J.; Wu, Y.; Arlinghaus, R.B. 1996: Sequences within the first exon of BCR inhibit the activated tyrosine kinases of c-Abl and the Bcr-Abl oncoprotein Cancer Research 56(22): 5120-5124
Strzelecka-Kiliszek, A.; Sobota, A. 2002: Sequential translocation of tyrosine kinases Lyn and Syk to the activated Fcgamma receptors during phagocytosis Folia Histochemica et Cytobiologica 40(2): 131-132
Jackson, P.K.; Paskind, M.; Baltimore, D. 1993: Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl Oncogene 8(7): 1943-1956
Resh, M.D. 1990: Membrane interactions of pp60v-src: a model for myristylated tyrosine protein kinases Oncogene 5(10): 1437-1444
Drescher, D.; Gockel, I.; Timm, S.; Berger, M.R.; Herzer, K.; Schmidtmann, I.; Junginger, T.; Galle, P.R.; Lang, H.; Moehler, M.; Schimanski, C.C. 2010: Does expression of receptor tyrosine kinases in gastric adenocarcinoma correlate with clinicopathological parameters? Hepato-Gastroenterology 57(98): 388-394
Chalandon, Y.; Schwaller, Jürg. 2005: Targeting mutated protein tyrosine kinases and their signaling pathways in hematologic malignancies Haematologica 90(7): 949-968